v3.25.2
Stockholders' Equity - Schedule of Non-vested Restricted Stock Units (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Jun. 30, 2025
Sep. 30, 2024
Time-Based Shares    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares) 2,587,386  
Granted (in shares) 3,327,503  
Vested (in shares) (1,073,647)  
Forfeited (in shares) (433,978)  
Ending balance (in shares) 4,407,264 2,587,386
Performance- Based Shares    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares) 1,119,437  
Granted (in shares) 2,130,431  
Vested (in shares) (267,890)  
Forfeited (in shares) (681,420)  
Ending balance (in shares) 2,300,558 1,119,437
Non-Vested Restricted Stock Units    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares) 3,706,823  
Granted (in shares) 5,457,934  
Vested (in shares) (1,341,537)  
Forfeited (in shares) (1,115,398)  
Ending balance (in shares) 6,707,822 3,706,823
Expected to vest (in shares) 6,707,822  
Weighted- Average Grant-Date Fair Value    
Beginning balance (in dollars per share) $ 23.51  
Granted (in dollars per share) 10.23  
Vested (in dollars per share) 28.75  
Forfeited (in dollars per share) 21.45  
Ending balance (in dollars per share) 13.05 $ 23.51
Expected to vest (in dollars per share) $ 13.05  
Weighted- Average Remaining Contractual Term (years)    
Weighted- Average Remaining Contractual Term (years)
Expected to vest (in years) 1 year 2 months 19 days  
Aggregate Intrinsic Value    
Beginning balance  
Ending balance
Expected to vest $ 68,420